D-0576-2025 Class II Ongoing

Recalled by Ascend Laboratories, LLC — Bedminster, NJ

FDA drug recall D-0576-2025 was initiated by Ascend Laboratories, LLC on Jul 21, 2025 and is designated Class II. Reason for recall: Failed Dissolution Specifications: low dissolution results The recall status is ongoing. Affected quantity: 8,568 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 20, 2025
Initiation Date
Jul 21, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,568 bottles

Product description

Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054, NDC 67877-501-30

Reason for recall

Failed Dissolution Specifications: low dissolution results

Distribution pattern

Nationwide in the USA

Code information

Lot 23121560, Exp 4/30/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0576-2025
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Ascend Laboratories, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0576-2025. Report a data issue: hello@regdatalab.com.